MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
Cai Li(Guangzhou University of Chinese Medicine), Youkun Jie(Nanchang University), Xiaoqing Hu(Peking University), Debao Zhuang(Jiangxi Maternal and Child Health Hospital), Kuanyong Shu(Nanchang University), Lü Y(Jiangxi Maternal and Child Health Hospital), Qi Guo(Medical University of South Carolina), Wenfeng He(Macau University of Science and Technology)
Cited by 45
Related Papers
Identification of Novel Genetic Markers of Breast Cancer Survival
|JNCI Journal of the National Cancer Institute|2015|245
The <scp>HAS‐BLED</scp> Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis
|Clinical Cardiology|2015|227
Bioinspired Mild Photothermal Effect-Reinforced Multifunctional Fiber Scaffolds Promote Bone Regeneration
|ACS Nano|2023|153
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
|Nature Communications|2014|123
Interplay between microRNAs and the STAT3 signaling pathway in human cancers
|Physiological Genomics|2013|106